Cancer screening in the United States during the second year of the COVID-19 pandemic
PURPOSE To examine whether cancer screening prevalence in the United States during
2021 has returned to prepandemic levels using nationally representative data. METHODS …
2021 has returned to prepandemic levels using nationally representative data. METHODS …
Impact of COVID-19 on cancer screening: A global perspective
L Allahqoli, A Mazidimoradi, H Salehiniya… - Current Opinion in …, 2022 - journals.lww.com
Screenings for all types of cancer fell sharply. In the chain of cancer management, delays in
any step are liable to change the outcome of the next step. Further long-term research will …
any step are liable to change the outcome of the next step. Further long-term research will …
The impact of the COVID-19 pandemic on breast and cervical cancer screening: a systematic review
S Elemes, P Stachteas, AB Haidich, A Mamopoulos… - in vivo, 2023 - iv.iiarjournals.org
Background/Aim: COVID-19 has dramatically impacted non-pandemic-related care,
including preventive medicine. Our objective was to quantify the alterations in the volume of …
including preventive medicine. Our objective was to quantify the alterations in the volume of …
Survival Among Patients With High-Risk Gastrointestinal Cancers During the COVID-19 Pandemic
LM Janczewski, AE Browner, JH Cotler… - JAMA network …, 2024 - jamanetwork.com
Importance Prior reports demonstrated that patients with cancer experienced worse
outcomes from pandemic-related stressors and COVID-19 infection. Patients with certain …
outcomes from pandemic-related stressors and COVID-19 infection. Patients with certain …
Patient-reported experiences of breast cancer screening, diagnosis, and treatment delay, and telemedicine adoption during COVID-19
S Du, L Carfang, E Restrepo, C Benjamin… - Current …, 2022 - mdpi.com
Purpose: To evaluate and quantify potential sociodemographic disparities in breast cancer
screening, diagnosis, and treatment due to the COVID-19 pandemic, and the use of …
screening, diagnosis, and treatment due to the COVID-19 pandemic, and the use of …
Alterations in cancer treatment during the first year of the COVID-19 pandemic in the US
LM Janczewski, J Cotler, RP Merkow, B Palis… - JAMA Network …, 2023 - jamanetwork.com
Importance The COVID-19 pandemic created challenges to the evaluation and treatment of
cancer, and abrupt resource diversion toward patients with COVID-19 put cancer treatment …
cancer, and abrupt resource diversion toward patients with COVID-19 put cancer treatment …
Cancer mortality and predictions for 2022 in selected Australasian countries, Russia, and Ukraine with a focus on colorectal cancer
Objective We aimed at predicting cancer mortality rates for the current year for the Russian
Federation, Ukraine, Israel, Hong Kong SAR, Japan, Korea, and Australia, with a focus on …
Federation, Ukraine, Israel, Hong Kong SAR, Japan, Korea, and Australia, with a focus on …
[HTML][HTML] Long-term effects of the interruption of the Dutch breast cancer screening program due to COVID-19: A modelling study
K Poelhekken, MJW Greuter, L de Munck, S Siesling… - Preventive …, 2023 - Elsevier
Due to COVID-19, the Dutch breast cancer screening program was interrupted for three
months with uncertain long-term effects. The aim of this study was to estimate the long-term …
months with uncertain long-term effects. The aim of this study was to estimate the long-term …
Reflections on the state of telehealth and cancer care research and future directions
CM Annunziata, WL Dahut, CL Willman… - JNCI …, 2024 - academic.oup.com
Telemedicine has routinely been used in cancer care delivery for the past 3 years. The
current state of digital health provides convenience and efficiency for both health-care …
current state of digital health provides convenience and efficiency for both health-care …
[HTML][HTML] The 2020 US cancer screening deficit and the timing of adults' most recent screen: a population-based cross-sectional study
J Semprini, R Ranganathan - Family Medicine and Community …, 2023 - ncbi.nlm.nih.gov
Objective In 2020, cancer screenings declined, resulting in a cancer screening deficit. The
significance of this deficit, however, has yet to be quantified from a population health …
significance of this deficit, however, has yet to be quantified from a population health …